These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1826673)

  • 1. Reduced numbers of CD4+ suppressor cells with subsequent expansion of CD8+ protective T cells as an explanation for the paradoxical state of enhanced resistance to Leishmania in T-cell deficient BALB/c mice.
    Hill JO
    Immunology; 1991 Feb; 72(2):282-6. PubMed ID: 1826673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania.
    Hill JO; Awwad M; North RJ
    J Exp Med; 1989 May; 169(5):1819-27. PubMed ID: 2523955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells.
    Müller I; Pedrazzini T; Kropf P; Louis J; Milon G
    Int Immunol; 1991 Jun; 3(6):587-97. PubMed ID: 1909563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica.
    Howard JG; Hale C; Liew FY
    J Exp Med; 1980 Sep; 152(3):594-607. PubMed ID: 6447751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY; Howard JG; Hale C
    J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between activated Leishmania major-specific CD4+ T lymphocytes and bone-marrow-derived cells in the exacerbation of murine cutaneous leishmaniasis.
    Mendonça SC; Titus RG; Louis JA
    Res Immunol; 1990; 141(9):865-78. PubMed ID: 1983098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica.
    Howard JG; Hale C; Liew FY
    J Exp Med; 1981 Mar; 153(3):557-68. PubMed ID: 6454739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines.
    Holaday BJ; Sadick MD; Wang ZE; Reiner SL; Heinzel FP; Parslow TG; Locksley RM
    J Immunol; 1991 Sep; 147(5):1653-8. PubMed ID: 1831830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.
    Bogdan C; Schröppel K; Lohoff M; Röllinghoff M; Solbach W
    Eur J Immunol; 1990 Dec; 20(12):2533-40. PubMed ID: 1980108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H; Scollay R
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for gamma delta + T cells during experimental infection of mice with Leishmania major.
    Rosat JP; MacDonald HR; Louis JA
    J Immunol; 1993 Jan; 150(2):550-5. PubMed ID: 8419488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the host response to Leishmania mexicana.
    Pérez H
    Ciba Found Symp; 1983; 99():157-73. PubMed ID: 6227462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W; Forberg K; Kammerer E; Bogdan C; Röllinghoff M
    J Immunol; 1986 Jul; 137(2):702-7. PubMed ID: 3487578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic immunization against experimental leishmaniasis. VI. Comparison of protective and disease-promoting T cells.
    Liew FY; Hodson K; Lelchuk R
    J Immunol; 1987 Nov; 139(9):3112-7. PubMed ID: 3312413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggravation of experimental cutaneous leishmaniasis in mice by administration of interleukin 3.
    Feng ZY; Louis J; Kindler V; Pedrazzini T; Eliason JF; Behin R; Vassalli P
    Eur J Immunol; 1988 Aug; 18(8):1245-51. PubMed ID: 2970970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of variables associated with promotion of resistance and its abrogation in T cell-reconstituted nude mice infected with Leishmania major.
    Moll H; Mitchell GF
    J Parasitol; 1988 Dec; 74(6):993-8. PubMed ID: 3264023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
    Liew FY; Hale C; Howard JG
    J Immunol; 1982 Apr; 128(4):1917-22. PubMed ID: 6120976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.
    Sacks DL; Scott PA; Asofsky R; Sher FA
    J Immunol; 1984 Apr; 132(4):2072-7. PubMed ID: 6230400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.